Other
Mobile Application Intervention
Mobile Application Intervention is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management
NCT04626830
completednot_applicable
Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
NCT02157519
completedphase_4
Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
NCT02996435
Clinical Trials (3)
Showing 3 of 3 trials
NCT04626830Not Applicable
Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management
NCT02157519Not Applicable
Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
NCT02996435Phase 4
Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3